An alpha-2 selective adrenergic agonist used as an antihypertensive agent. [PubChem]
Drug Type:
Small Molecule; Approved
Pharmacology:
Guanabenz, a centrally acting α-2 adrenergic agonist, is indicated for treatment of hypertension.
Mechanism of Action:
Guanabenz's antihypertensive effect is thought to be due to central alpha-adrenergic stimulation, which results in a decreased sympathetic outflow to the heart, kidneys, and peripheral vasculature in addition to a decreased systolic and diastolic blood pressure and a slight slowing of pulse rate. Chronic administration of guanabenz also causes a decrease in peripheral vascular resistance.
The DrugBank database is a unique bioinformatics and cheminformatics resource that combines detailed drug (i.e. chemical, pharmacological and pharmaceutical) data with comprehensive drug target (i.e. sequence, structure, and pathway) information.
Authors:
David S Wishart, Craig Knox, An Chi Guo et al.
Organization: Department of Computing Science, Univers…
A reference collection of genome-wide transcriptional expression data from cultured human cells treated with bioactive small molecules that enable the discovery of functional connections between drugs, genes and diseases through the transitory feature of common gene-expression changes.
Authors:
Lamb J
Organization: Broad Institute
Seven Cambridge Center
C…
No NextBio users were found for “Wy 8678”. Complete
your user profile with your interests, if you want others to find you within the NextBio community.